|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.80 USD | +6.19% |
|
+0.03% | -27.20% |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 1,458 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | -25.85% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 1,302 | 1,226 | 1,121 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | -30.45% | -5.86% | -8.6% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 628x | 84.7x | 47.7x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 2.57x | 2.31x | 2.03x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -5x | 0x | 0.6x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 2.41x | 2.15x | 1.91x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 2.15x | 1.81x | 1.47x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 16.1x | 12.6x | 9.41x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 227x | 58.4x | 29.8x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 24.1x | 29.9x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 4.14% | 3.34% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.0459 | 0.34 | 0.6043 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 605 | 678.5 | 763.4 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 80.76 | 97.38 | 119.1 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 5.738 | 20.99 | 37.67 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 2.66 | 17.48 | 30.62 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -156 | -232.3 | -337.7 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 28.80 | 28.80 | 28.80 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,641 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 628x | 2.15x | 16.13x | - | 1.46B | |
| 22.24x | 3.3x | 12.38x | 2.88% | 154B | |
| 19.94x | 3.44x | 12.38x | 3.6% | 102B | |
| 34.44x | 8.39x | 21.94x | 1.17% | 56.51B | |
| 14.32x | 0.17x | 10.77x | 0.87% | 52.89B | |
| 35.88x | 2.9x | 9.94x | 2.67% | 39.67B | |
| 34.4x | 1.28x | 11.29x | 0.23% | 30.39B | |
| 29.61x | 5.28x | 16.83x | -.--% | 27.96B | |
| 38.95x | 6.73x | 24.3x | 0.27% | 23.17B | |
| 23.99x | 3.06x | 12.49x | 1.35% | 20.35B | |
| Average | 88.18x | 3.67x | 14.84x | 1.45% | 50.8B | |
| Weighted average by Cap. | 27.08x | 3.67x | 13.82x | 2.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
